UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Schizophrenia research, 2012-11, Vol.141 (2-3), p.144-152

2012

Volltextzugriff (PDF)

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders

Journal of Huntington's disease, 2018-01, Vol.7 (3), p.355-366

2018

Volltextzugriff (PDF)

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report

The journal of clinical psychiatry, 2002-01, Vol.63 (1), p.15-20

2002

Volltextzugriff (PDF)

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease

PLoS currents, 2011-08, Vol.3, p.RRN1260-RRN1260

2011

Volltextzugriff (PDF)

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Sleep medicine, 2011-02, Vol.12 (2), p.134-141

2011

Volltextzugriff (PDF)

Population admixture modulates risk for alcohol dependence

Human genetics, 2009-06, Vol.125 (5-6), p.605-613

2009

Volltextzugriff (PDF)

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

Movement disorders, 2011-04, Vol.26 (5), p.877-884

2011

Volltextzugriff (PDF)

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease

PLoS currents, 2011-08, Vol.3, p.RRN1259-RRN1259

2011

Volltextzugriff (PDF)

An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease

PLoS currents, 2011-09, Vol.3, p.RRN1261-RRN1261

2011

Volltextzugriff (PDF)

Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

Neuropsychopharmacology, 2003-07, Vol.28 (7), p.1292-1299

2003

Volltextzugriff (PDF)

Advances in Treatment of Bipolar Disorder: Review of Psychiatry, Volume 24

The American Journal of Psychiatry, 2007-01, Vol.164 (1), p.179-179

VAN KAMMEN, DANIEL P.

2007

Volltextzugriff (PDF)

Pharmacokinetics, Tolerability, and Safety of ACP-103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.704-714

2007

Volltextzugriff (PDF)

Membrane Phospholipids and Cytokine Interaction in Schizophrenia

Disorders of Synaptic Plasticity and Schizophrenia, 2004, Vol.59, p.297-326

2004

Volltextzugriff (PDF)

Assessment of depression, anxiety and apathy in prodromal and early huntington disease

PLoS currents, 2011-06, Vol.3, p.RRN1242-RRN1242

2011

Volltextzugriff (PDF)

The Effects of Food on the Pharmacokinetics of a Formulated ACP-103 Tablet in Healthy Volunteers

Journal of clinical pharmacology, 2007-07, Vol.47 (7), p.915-919

2007

Volltextzugriff (PDF)

Association study of DTNBP1 with schizophrenia in a US sample

Psychiatric genetics, 2009-12, Vol.19 (6), p.292-304

2009

Volltextzugriff (PDF)

Assessment of cognitive symptoms in prodromal and early huntington disease

PLoS currents, 2011-10, Vol.3, p.RRN1250-RRN1250

2011

Volltextzugriff (PDF)

Confirmation of a Two-Factor Model of Premorbid Adjustment in Males with Schizophrenia

Schizophrenia bulletin, 2001, Vol.27 (1), p.39-46

2001

Volltextzugriff (PDF)

Assessment of motor symptoms and functional impact in prodromal and early huntington disease

PLoS currents, 2011-06, Vol.2, p.RRN1244-RRN1244

2011

Volltextzugriff (PDF)

Assessing behavioural manifestations prior to clinical diagnosis of huntington disease: "anger and irritability" and "obsessions and compulsions"

PLoS currents, 2011-07, Vol.3, p.RRN1241-RRN1241

2011

Volltextzugriff (PDF)

Utility of WAIS-R short forms in schizophrenia

Schizophrenia research, 1997-08, Vol.26 (2), p.163-172

1997

Volltextzugriff (PDF)

Factor structure of neurologic examination abnormalities in unmedicated schizophrenia

Psychiatry research, 2000-09, Vol.95 (3), p.237-243

2000

Volltextzugriff (PDF)

Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd ed. Essential Psychopharmacology of Depression and Bipolar Disorder

The American journal of psychiatry, 2001-09, Vol.158 (9), p.1538-a-1539

VAN KAMMEN, DANIEL P.

2001

Volltextzugriff (PDF)

Natural history of Huntington disease

JAMA neurology, 2013-12, Vol.70 (12), p.1520

2013

Volltextzugriff (PDF)

CALCYON gene variation, schizophrenia, and cocaine dependence

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2004-02, Vol.125B (1), p.25-30

2004

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Aktive Filter

ThemaPsychoses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(219)

Publikationsform

Artikel
(223)
Buchkapitel
(39)
Reviews
(10)
Bücher
(1)

Sprache

Englisch
(273)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Humans
(131)
Life Sciences & Biomedicine
(126)
Psychiatry
(101)
Male
(97)
Adult
(91)
Female
(68)
Middle Aged
(60)
Schizophrenia - Drug Therapy
(54)
Schizophrenia
(52)
Biological And Medical Sciences
(44)
Medical Sciences
(44)
Schizophrenic Psychology
(40)
Adolescent
(39)
Psychology. Psychoanalysis. Psychiatry
(38)
Alternative & Renewable Energy Sources & Technology
(36)
Environmental Economics
(36)
The Environment
(36)
Neurosciences & Neurology
(34)
Double-Blind Method
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

Population admixture modulates risk for alcohol dependence

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease

An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease

Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

Advances in Treatment of Bipolar Disorder: Review of Psychiatry, Volume 24

Pharmacokinetics, Tolerability, and Safety of ACP-103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers

Membrane Phospholipids and Cytokine Interaction in Schizophrenia

Assessment of depression, anxiety and apathy in prodromal and early huntington disease

The Effects of Food on the Pharmacokinetics of a Formulated ACP-103 Tablet in Healthy Volunteers

Association study of DTNBP1 with schizophrenia in a US sample

Assessment of cognitive symptoms in prodromal and early huntington disease

Confirmation of a Two-Factor Model of Premorbid Adjustment in Males with Schizophrenia

Assessment of motor symptoms and functional impact in prodromal and early huntington disease

Assessing behavioural manifestations prior to clinical diagnosis of huntington disease: "anger and irritability" and "obsessions and compulsions"

Utility of WAIS-R short forms in schizophrenia

Factor structure of neurologic examination abnormalities in unmedicated schizophrenia

Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd ed. Essential Psychopharmacology of Depression and Bipolar Disorder

Natural history of Huntington disease

CALCYON gene variation, schizophrenia, and cocaine dependence

Aktive Filter

Suchergebnisse filtern